My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    1.

    Evaluation of herbal cannabis characteristics by medical users: a randomized trial.

    Ware MA, Ducruet T, Robinson AR.

    Harm Reduct J. 2006 Nov 13;3:32.PMID: 17101054 [PubMed]Free PMC ArticleFree textRelated citations

    2.

    Who is using cannabis as a medicine and why: an exploratory study.

    Ogborne AC, Smart RG, Weber T, Birchmore-Timney C.

    J Psychoactive Drugs. 2000 Oct-Dec;32(4):435-43.PMID: 11210205 [PubMed - indexed for MEDLINE]Related citations

    4.

    Patterns of cannabis use among patients with multiple sclerosis.

    Clark AJ, Ware MA, Yazer E, Murray TJ, Lynch ME.

    Neurology. 2004 Jun 8;62(11):2098-100.PMID: 15184623 [PubMed - indexed for MEDLINE]Related citations

    5.

    Cannabis use in Spanish patients with multiple sclerosis: fulfilment of patients' expectations?

    Martínez-Rodríguez JE, Munteis E, Carreño M, Blanco Y, Roquer J, Abanades S, Graus F, Saiz A.

    J Neurol Sci. 2008 Oct 15;273(1-2):103-7. Epub 2008 Aug 8.PMID: 18691726 [PubMed - indexed for MEDLINE]Related citations

    6.

    [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents]

    Chabrol H, Mabila JD, Chauchard E, Mantoulan R, Rousseau A.

    Encephale. 2008 Jan;34(1):8-16. Epub 2007 Sep 4. French. PMID: 18514145 [PubMed - indexed for MEDLINE]Related citations

    8.

    Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.

    Russo EB, Guy GW, Robson PJ.

    Chem Biodivers. 2007 Aug;4(8):1729-43. Review.PMID: 17712817 [PubMed - indexed for MEDLINE]Related citations

    9.

    Survey of Australians using cannabis for medical purposes.

    Swift W, Gates P, Dillon P.

    Harm Reduct J. 2005 Oct 4;2:18.PMID: 16202145 [PubMed]Free PMC ArticleFree textRelated citations

    10.

    Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

    Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

    Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. Review.PMID: 18485271 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    11.

    Self-efficacy, social support and service integration at medical cannabis facilities in the San Francisco Bay area of California.

    Reiman AE.

    Health Soc Care Community. 2008 Jan;16(1):31-41.PMID: 18181813 [PubMed - indexed for MEDLINE]Related citations

    12.

    Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.

    Ramaekers JG, Kauert G, Theunissen EL, Toennes SW, Moeller MR.

    J Psychopharmacol. 2009 May;23(3):266-77. Epub 2008 Aug 21.PMID: 18719045 [PubMed - indexed for MEDLINE]Related citations

    13.

    Tissue adhesives for simple traumatic lacerations.

    Beam JW.

    J Athl Train. 2008 Apr-Jun;43(2):222-4.PMID: 18345349 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    14.

    Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.

    Lowe RH, Abraham TT, Darwin WD, Herning R, Cadet JL, Huestis MA.

    Drug Alcohol Depend. 2009 Nov 1;105(1-2):24-32. Epub 2009 Jul 23.PMID: 19631478 [PubMed - indexed for MEDLINE]Related citations

    15.

    Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.

    Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, Kelly ME, Rowbotham MC, Petersen KL.

    Neurology. 2007 Feb 13;68(7):515-21.PMID: 17296917 [PubMed - indexed for MEDLINE]Related citations

    16.

    Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.

    Hunault CC, Mensinga TT, de Vries I, Kelholt-Dijkman HH, Hoek J, Kruidenier M, Leenders ME, Meulenbelt J.

    Psychopharmacology (Berl). 2008 Dec;201(2):171-81. Epub 2008 Aug 10.PMID: 18695931 [PubMed - indexed for MEDLINE]Related citations

    17.

    Multiple sclerosis and cannabis: a cognitive and psychiatric study.

    Ghaffar O, Feinstein A.

    Neurology. 2008 Jul 15;71(3):164-9. Epub 2008 Feb 13.PMID: 18272863 [PubMed - indexed for MEDLINE]Related citations

    18.

    Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.

    Young TN, Arens FJ, Kennedy GE, Laurie JW, Rutherford G.

    Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002835. Review.PMID: 17253483 [PubMed - indexed for MEDLINE]Related citations

    19.

    Cannabis; adverse effects from an oromucosal spray.

    Scully C.

    Br Dent J. 2007 Sep 22;203(6):E12; discussion 336-7. Epub 2007 Aug 17.PMID: 17703180 [PubMed - indexed for MEDLINE]Related citations

    20.

    Absorbent products for urinary/faecal incontinence: a comparative evaluation of key product designs.

    Fader M, Cottenden A, Getliffe K, Gage H, Clarke-O'Neill S, Jamieson K, Green N, Williams P, Brooks R, Malone-Lee J.

    Health Technol Assess. 2008 Jul;12(29):iii-iv, ix-185. Review.PMID: 18547500 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk